(Q40205472)

18 September 2017

title

Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation (English)

1 reference

African swine fever virus

18 September 2017

main subject

0 references

1 reference

3

Martin Beer

1 reference

18 September 2017

1

Sandra Blome

1 reference

18 September 2017

Claudia Gabriel

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

27 May 2014

1 reference

18 September 2017

1 reference

18 September 2017

volume

32

1 reference

18 September 2017

issue

31

1 reference

18 September 2017

page(s)

3879-3882

1 reference

African swine fever: an epidemiological update.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

African swine fever (ASF): five years around Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

African swine fever: how can global spread be prevented?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Apoptosis in porcine macrophages infected in vitro with African swine fever virus (ASFV) strains with different virulence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Characterization of African swine fever virus IAP homologue expression in porcine macrophages infected with different virulence isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Methods for growing and titrating African swine fever virus: field and laboratory samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Development of a TaqMan PCR assay with internal amplification control for the detection of African swine fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Immunogenicity of a killed whole Neospora caninum tachyzoite preparation formulated with different adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

IFN-g response to vaccination against tuberculosis in dairy heifers under commercial settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Antibody-mediated neutralization of African swine fever virus: myths and facts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

Passively transferred African swine fever virus antibodies protect swine against lethal infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.051

10.1016/J.VACCINE.2014.05.051

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference